Insider Transactions in Q1 2021 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 03
2021
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
1,554
-0.37%
|
$332,556
$214.25 P/Share
|
|
Feb 03
2021
|
Stuart A Arbuckle EVP, COO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,554
+2.13%
|
$133,644
$86.52 P/Share
|
|
Feb 03
2021
|
Stuart A Arbuckle EVP, COO |
BUY
Grant, award, or other acquisition
|
Direct |
34,778
+16.98%
|
-
|
|
Feb 03
2021
|
Carmen Bozic EVP and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
21,951
+27.12%
|
-
|
|
Feb 03
2021
|
Reshma Kewalramani CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
44,935
+20.61%
|
-
|
|
Feb 03
2021
|
Jeffrey M Leiden Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
8,599
-9.98%
|
$1,848,785
$215.03 P/Share
|
|
Feb 03
2021
|
Jeffrey M Leiden Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
83,888
+33.43%
|
-
|
|
Feb 03
2021
|
Michael Parini EVP, Chief Adm, Leg & BD Off |
SELL
Open market or private sale
|
Direct |
400
-0.23%
|
$86,400
$216.91 P/Share
|
|
Feb 03
2021
|
Michael Parini EVP, Chief Adm, Leg & BD Off |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+0.69%
|
$34,400
$86.52 P/Share
|
|
Feb 03
2021
|
Michael Parini EVP, Chief Adm, Leg & BD Off |
BUY
Grant, award, or other acquisition
|
Direct |
30,389
+18.22%
|
-
|
|
Feb 03
2021
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
BUY
Grant, award, or other acquisition
|
Direct |
32,077
+15.46%
|
-
|
|
Feb 03
2021
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
BUY
Grant, award, or other acquisition
|
Direct |
20,719
+22.41%
|
-
|
|
Feb 03
2021
|
Paul M Silva SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,080
+14.3%
|
-
|
|
Feb 03
2021
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
BUY
Grant, award, or other acquisition
|
Direct |
22,960
+21.86%
|
-
|
|
Feb 03
2021
|
Charles F Wagner Jr EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,951
+25.7%
|
-
|